Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Patterson

Showing results (461-470 of 599) with videos related to

Pageof 60
Sort By:
Antimicrobial Agents and Chemotherapy|March 11, 2015
Efficacy of the investigational echinocandin ASP9726 in a guinea pig model of invasive pulmonary aspergillosisNathan P Wiederhold, Laura K Najvar, Satoru Matsumoto, et al.
Clinical and Experimental Immunology|August 1, 1992
IgA-containing immune complexes after challenge with food antigens in patients with IgA nephropathyS Jackson, Z Moldoveanu, K A Kirk, et al.
Journal of the American Veterinary Medical Association|November 1, 1988
Research on genetic diseases: reciprocal benefits to animals and manD F Patterson, M E Haskins, P F Jezyk, et al.
Medical Mycology|March 17, 2007
Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipientSteven D Westbrook, William R Kirkpatrick, Cesar O Freytes, et al.
Journal of Clinical Pathology|November 4, 2011
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosisElaine McCulloch, Gordon Ramage, Ranjith Rajendran, et al.
Experimental Parasitology|February 23, 2011
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replicationMichael J Brumlik, Standwell Nkhoma, Mark J Kious, et al.
Open Forum Infectious Diseases|August 6, 2020
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19George R Thompson Iii, Oliver A Cornely, Peter G Pappas, et al.
Virulence|June 9, 2016
Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungiNathan P Wiederhold, Thomas F Patterson, Anand Srinivasan, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2017
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trialDimitrios P Kontoyiannis, Dominik Selleslag, Kathleen Mullane, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2024
Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin BTeclegiorgis Gebremariam, Sondus Alkhazraji, Yiyou Gu, et al.
Pageof 60

Showing results (461-470 of 599) with videos related to

Sort By:
Pageof 60
Antimicrobial Agents and Chemotherapy|March 11, 2015
Efficacy of the investigational echinocandin ASP9726 in a guinea pig model of invasive pulmonary aspergillosisNathan P Wiederhold, Laura K Najvar, Satoru Matsumoto, et al.
Clinical and Experimental Immunology|August 1, 1992
IgA-containing immune complexes after challenge with food antigens in patients with IgA nephropathyS Jackson, Z Moldoveanu, K A Kirk, et al.
Journal of the American Veterinary Medical Association|November 1, 1988
Research on genetic diseases: reciprocal benefits to animals and manD F Patterson, M E Haskins, P F Jezyk, et al.
Medical Mycology|March 17, 2007
Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipientSteven D Westbrook, William R Kirkpatrick, Cesar O Freytes, et al.
Journal of Clinical Pathology|November 4, 2011
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosisElaine McCulloch, Gordon Ramage, Ranjith Rajendran, et al.
Experimental Parasitology|February 23, 2011
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replicationMichael J Brumlik, Standwell Nkhoma, Mark J Kious, et al.
Open Forum Infectious Diseases|August 6, 2020
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19George R Thompson Iii, Oliver A Cornely, Peter G Pappas, et al.
Virulence|June 9, 2016
Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungiNathan P Wiederhold, Thomas F Patterson, Anand Srinivasan, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2017
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trialDimitrios P Kontoyiannis, Dominik Selleslag, Kathleen Mullane, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2024
Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin BTeclegiorgis Gebremariam, Sondus Alkhazraji, Yiyou Gu, et al.
Pageof 60